Sort
8,912 grants matching “sars cov 2”
Increasing representation of Black communities in COVID-19 home testing and surveillance data
$570,231Heather Bradley · Emory University · U01 · FY2023 · MD
Defining PRC2 complex epigenomic control in alveolar progenitor cells
$569,920William John Zacharias · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
$569,896Jianwen Que · Columbia University Health Sciences · R01 · FY2024 · HL
Evaluation of Operation Safer Ground: A Community-Level Rapid Housing Intervention for People Vulnerable to COVID-19.
$569,825Jennifer Lorvick · Research Triangle Institute · R01 · FY2021 · MD
The ADELANTE Trial: Testing a multi-level approach for improving household food insecurity and glycemic control among Latinos with diabetes
$569,678Lisa Goldman Rosas · Stanford University · R01 · FY2024 · MD
Addressing COVID 19 Vaccine Hesitancy in Rural Community Pharmacies Reducing Disparities Through an Implementation Science Approach
$569,232Delesha Miller Carpenter · Univ Of North Carolina Chapel Hill · R01 · FY2024 · MD
Anchimerically Activatable Anti-Zika/Dengue ProTides
$568,956Carston R. Wagner · University Of Minnesota · R01 · FY2025 · AI
Anchimerically Activatable Anti-Zika/Dengue ProTides
$568,956Carston R. Wagner · University Of Minnesota · R01 · FY2022 · AI
Anchimerically Activatable Anti-Zika/Dengue ProTides
$568,956Carston R. Wagner · University Of Minnesota · R01 · FY2024 · AI
Anchimerically Activatable Anti-Zika/Dengue ProTides
$568,956Carston R. Wagner · University Of Minnesota · R01 · FY2023 · AI
A wastewater approach to viral transmission, evolution, and ecology
$568,909Fuqing Wu · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · AI
Influenza & COVID Obstetric and Perinatal Epidemiology Study in India
$568,497Patricia L Hibberd · Boston University Medical Campus · R01 · FY2022 · HD
Human monoclonal antibodies against SARS-CoV-2
$568,478Joshua Hoong Yu Tan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Modeling the Coupled Dynamics of COVID-19 Transmission and Protective Behaviors
$567,938Raffaele Vardavas · Rand Corporation · R01 · FY2022 · AI
Triple humanized ACE2-TMPRSS-FcGRT mouse models for COVID research in the C57BU6 and BALBIc backgrounds.
$566,896Kurt Jarnagin · Synbal, Inc. · R44 · FY2023 · AI
Transmission of CoV-2 and the Impact of Spike Protein Evolution
$566,583Adrianus Cm Boon · Washington University · R01 · FY2024 · AI
Transmission of CoV-2 and the Impact of Spike Protein Evolution
$566,572Adrianus Cm Boon · Washington University · R01 · FY2025 · AI
Structure-guided immunogens to elicit pan-coronavirus B cell responses
$566,400Aaron Gregory Schmidt · Washington University · P01 · FY2025 · AI
Data Science COre
$565,611Yu Shyr · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
SARS-CoV-2 and Social Determinants of Health Impact on Inflammation Associated Depression Risk (SSIDR)
$565,604Linda Y. Kim · University Of Texas At Austin · R01 · FY2025 · MH
Assessing the long-term impacts of the COVID-19 pandemic on disparities in cancer screening and follow-up (RESTORE)
$565,309Gloria D Coronado · University Of Arizona · R01 · FY2024 · CA
HOPE Training Grant
$565,030Scott L Letendre · University Of California, San Diego · T32 · FY2025 · AI
The effect of HIV on SARS-CoV-2 transmission and emergence of variants of concern
$565,009Sanghyuk Sam Shin · University Of California-Irvine · R01 · FY2024 · AI
The Molecular and Cellular Basis of Infectious Diseases (MCBID) Program
$564,671Arturo Casadevall · Johns Hopkins University · T32 · FY2022 · AI
Systems Immunogenetics of Biodefense and Emerging Pathogens in the Collaborative Cross
$564,671Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2020 · AI